| Story Views | |
| Now: | |
| Last Hour: | |
| Last 24 Hours: | |
| Total: | |
Catalyst Biosciences slumps after announcing plans to raise US$18mln
Friday, April 7, 2017 8:57
% of readers think this story is Fact. Add your two cents.
Shares in Catalyst Biosciences Inc (NASDAQ:CBIO) were marked down more than $2 to US$5.341 as it announced plans to raise US$18mln.
The clinical stage biopharmaceutical company focused on blood-related diseases announced an offering of Class A units, priced at US$5, and Class B units, priced at US$1,000.
The class A units comprise one Catalyst shares plus a warrant to buy half a share, with an exercise price of US$5.50.
The class B units comprise one preferred share, convertible into 200 shares of common stock, and a warrant to purchase 100 shares of common stock at an exercise price of US$5.50.
Story by ProactiveInvestors
Source: http://www.proactiveinvestors.com/companies/news/176172/catalyst-biosciences-slumps-after-announcing-plans-to-raise-us18mln-176172.html
